Skip to main content

Table 1 Demographic data for ONFH patients and healthy controls

From: Attenuated serum vasoactive intestinal peptide concentrations are correlated with disease severity of non-traumatic osteonecrosis of femoral head

 

ONFH patients (n=105)

Healthy controls (n=103)

P value

Age (Y)

48.8±10.2

47.7±9.4

0.413

Sex (F/M)

35/70

37/66

0.155

BMI (kg/m2)

23.1±2.0

23.2±2.6

0.168

Disease duration (M)

85 (5–210)

/

 

VAS scores

5.0±1.7

/

 

HSS scores

68.8±12.1

/

 

FICAT stage (2/3/4)

34/37/34

/

 

Serum VIP levels (pg/mL)

209.6±37.2

268.5±41.0

<0.001

Serum TNF-α levels (pg/mL)

1.41±0.10

1.03±0.04

<0.001

Serum IL-1β levels (pg/mL)

3.45±0.12

1.05±0.05

<0.001

Serum C-MSF levels (pg/mL)

70.27±12.16

67.05±14.14

0.179

  1. All data are given as mean value ± SD or median